Real-time enrollment status for this metastatic hormone-sensitive prostate cancer (mhspc) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 10:00 PM UTC
| NCT Number | NCT07216248 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| Phase | PHASE2 |
| Target Enrollment | 160 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Utah |
| Last Updated on CT.gov | June 23, 2026 (Jun 23, 2026) |
As of August 29, 2026: Clinical trial NCT07216248 is currently recruiting participants. This phase2 study for metastatic hormone-sensitive prostate cancer (mhspc) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Utah. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216248 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216248 was last updated Jun 23, 2026 (June 23, 2026). HelloStudys verifies this status automatically.